Advances in the Treatment of Lymphoma (lymphoma13)
Venue: America Square Conference Centre
Location: London, United Kingdom
Event Date/Time: Oct 18, 2013 / 8:00 am - (GMT) | End Date/Time: Oct 18, 2013 / 4:30 pm - (GMT) |
Early Registration Date: Jul 01, 2013 |
Description
Research into new therapies for lymphoma is fast-paced, with new developments taking place all the time, so it is important for clinicians and healthcare professionals within the field to keep up to date with the latest evidence. Advances in the Treatment of Lymphoma will examine the current and emerging treatments for the different types of lymphoma, with the aim of updating knowledge and arming participants with practical information that can positively influence every day clinical practice.
Benefits of attending Advances in the Treatment of Lymphoma: • Hear updates about new research and clinical trials, including targeted personalised therapies • Evaluate the current treatment strategies for Hodgkin’s and non-Hodgkin’s lymphoma and refractory lymphoma • Gain insights into optimising patient care, including long-term follow up care and palliative care • Take part in treatment case studies on optimal management of Hodgkin’s, B-cell and T-cell lymphoma • Share and exchange ideas with the leading practitioners in the field
Who should attend? Advances in the Treatment of Lymphoma will be of particular interest to the following: • Haemato-oncologists • Haematologists • Clinical oncologists • Haematopathologists • Clinical immunologists • Specialists in transplantation • Nurse specialists and nurse practitioners in haematology, oncology and transplantation • Researchers in haematology, oncology and immunology • All trainees in these disciplines
Venue
Conference Speakers
Dr Andrew Davies
Professor Ray Powles (CBE)
Dr Graham Collins
Dr Chris Hatton
Dr Ruth Pettengell
Dr Paul Fields
Dr Claire Dearden
Dr Robert Marcus
Dr Karl Peggs (tbc)
Dr Alastair Smith
Dr Martin Howard